J&J delays Ottava robot rollout as global medtech business boosts Q3 sales

The healthcare giant is the first procedure-dependent medtech to announce earnings this quarter, potentially foreshadowing what others in the industry will report in the coming weeks.

Read the full article here

Related Articles